Delivery Order SPE2DB20D7059-SPE2DB24FPZQ3
Award Date 2/22/24
Potential Completion Date 2/23/24
Potential Value $14K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $37,452.40 for the supply of 4563971703 - TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to provide pharmaceutical products and medical supplies to military treatment...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $27,368.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML pharmaceuticals. This delivery order falls under an indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,421.00 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value of up to $999,999,999.00 and runs through December 31, 2025. The IDC serves as the primary contract...
- The Defense Logistics Agency (DLA) awarded a $5,617.92 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564391256 TYPHIM VI 25 MCG/0.5 ML VIAL 10ML pharmaceuticals. This delivery order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML pharmaceuticals. The contract has a completion date of February 5, 2024 and a potential value of $3,586.12. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which was not set aside for any particular business type. This order is part...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,044.43 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical sourcing and distribution company. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a vaccine, with a completion date of March 6, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $5,508.43 to provide TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML, a pharmaceutical product, with a period of performance through February 26, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued up to $999,999,999.00 with a performance period through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $4,681.60 to Amerisourcebergen Drug Corp, a division of the global pharmaceutical company Amerisourcebergen Corporation, for the supply of 4563795308 - TYPHIM VI 25 MCG/0.5 ML VIAL 10ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML pharmaceutical products. The $2,140.52 order has a completion date of February 27, 2024 and was issued under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025. This IDC serves as Amerisourcebergen's primary contract vehicle to deliver...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,872.64 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of TYPHIM VI 25 MCG/0.5 ML VIAL 10ML, a pharmaceutical product, with a completion date of March 5, 2024. This delivery order is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) between...
Teaming
Find teaming partners for this award
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB24FPZQ3Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $13,686.00 to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, to provide 4563731633 TYPHIM VI 25 MCG/0.5 ML SYRNG 0.5ML. This delivery order is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as the primary vehicle for Amerisourcebergen Drug Corp to deliver a comprehensive range of pharmaceutical products and medical supplies to support Department of Defense military treatment programs and facilities worldwide. The contract does not have a set-aside designation.
Generated 5/23/24, 10:26 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.7k | 2/22/24 |